Clinical Trial Update: Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetic Cases [Phase 2]

View source ↗

Summary

Phase 2 trial investigating meal-time administration of exenatide for glycemic control in adults with Type 1 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• EXENATIDE (EXENATIDE)

Snippet

Sponsor: Filip Krag Knop | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: COMPLETED